Publications by authors named "Alonso Valdes"

Claim this Profile
I
Is cholecystectomy a real risk factor for Metabolic dysfunction-associated steatotic liver disease (MASLD)? A longitudinal cohort study from a population with a high burden of gallbladder diseases.
Oscar Corsi, Constanza Jara, Magdalena Fernandez, Antonia Pastore, Diego Pérez, Alonso Valdes

Clin Res Hepatol Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HEBERSaVax immunotherapy combined with first-line chemotherapy in advanced ovarian cancer: Phase II CENTAURO-4 trial results.
Francisco Hernández-Bernal, Katty-Hind Selman-Housein Bernal, Monica Bequet-Romero, Yenima Martín-Bauta, Karem M Catasús-Álvarez

Int J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of Abdala COVID-19 subunit vaccine in children and adolescents: An open-label, single-arm, phase 2 trial (MEÑIQUE).
Francisco Hernández-Bernal, Enrique Noa-Romero, Joel Quintana-Guerra, Cristina O Chávez-Chong, Yenima Martín-Bauta

Vaccine· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety assessment of a SARS-CoV-2 recombinant spike RBD protein vaccine (Abdala) in paediatric ages 3-18 years old: a double-blinded, multicentre, randomised, phase 1/2 clinical trial (ISMAELILLO study).
Zurina Cinza-Estévez, Sonia Resik-Aguirre, Nelvis L Figueroa-Baile, Rachel Oquendo-Martínez, Ivan Campa-Legrá

EClinicalMedicine· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study).
Francisco Hernández-Bernal, Maria C Ricardo-Cobas, Yenima Martín-Bauta, Ernesto Rodríguez-Martínez, Klaudia Urrutia-Pérez

Lancet Reg Health Am· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study).
Francisco Hernández-Bernal, Maria C Ricardo-Cobas, Yenima Martín-Bauta, Zadis Navarro-Rodríguez, Marjoris Piñera-Martínez

EClinicalMedicine· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Paroxysmal dyskinesia secondary to non-ketotic hyperglycaemia with a diabetic onset].
Josep M Aragonès, Clara Blanch, Gerard Corominas, Francisco Alonso-Valdés, Sebastià Alfonso

Rev Neurol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Benign intracranial hypertension secondary to hypoparathyroidism].
Josep Maria Aragonès, Francisco Alonso-Valdés

Rev Neurol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Cerebrovascular accidents in Osona borough. Cardiovascular risks factors].
C Sanclemente Ansó, F Alonso Valdés, E Rovira Pujol, D Vigil Sanmartín

An Med Interna· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A retroperitoneal pseudotumor as the form of presentation of extrapulmonary tuberculosis].
F Alonso Valdés, J Espinach Alvarós, L Lu Cortez

Med Clin (Barc)· March 1991

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis